Moderna and Merck's Phase 2b study results for mRNA-4157 combined with Keytruda, showing improvements in recurrence-free and distant metastasis-free survival for high-risk melanoma patients. Phase 3 trials are now underway for melanoma and non-small cell lung cancer.
Spotify shares surge as the company hiked U.S. premium plan prices. Subscribers will be informed via email about the changes: individual plans rising to $11.99 from $10.99, duo plans to $16.99 from $14.99, and family plans to $19.99 from $16.99. This move aims to boost profit margins amidst competition from Apple and Amazon, focusing on premium services that drive most of Spotify's revenue.
Reddit Inc (NYSE:RDDT) shares are trading higher Monday after an account associated with GameStop Corp (NYSE:GME) trader Keith Gill posted on the platform for the first time in three years. Gill, best known as "Roaring Kitty" on YouTube and X or "DeepF***ingValue" on Reddit, posted a screenshot to Reddit suggesting he currently has a $116 million bet on GameStop.
Bio-Path Holdings shares are trading higher Monday after the company announced the presentation of interim results from its Phase 2 study of prexigebersen (BP1001) in combination with decitabine and venetoclax for the treatment of acute myeloid leukemia (AML).
GSK shares fell as the Delaware State Court allowed over 70,000 lawsuits regarding the discontinued heartburn drug Zantac (ranitidine) to proceed. This ruling contradicts a Federal Court's 2022 decision dismissing similar cases, potentially increasing GSK's liability.
CrowdStrike is due to report first-quarter earnings results for fiscal 2025 after the market close on Tuesday. The company is expected to report earnings of 90 cents per share and revenue of $904.665 million, according to estimates from Benzinga Pro.
SAIC reported 9% revenue decline in Q1 2025, but beat analyst estimates. Adjusted EPS in line with consensus. Divestiture & contract completions led to decline. FY25 outlook reiterated.